These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 13934284)

  • 1. Triethylene thiophosphoramide in the prevention of pterygium recurrence.
    MEACHAM CT
    Am J Ophthalmol; 1962 Nov; 54():751-3. PubMed ID: 13934284
    [No Abstract]   [Full Text] [Related]  

  • 2. Triethylene thiophosphoramide (thio-tepa) and pterygium.
    Liddy BS; Morgan JF
    Am J Ophthalmol; 1966 May; 61(5 Pt 1):888-90. PubMed ID: 16874990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RECURRENT PTERYGIUM: USE OF TOPICAL TRIETHYLENE THIOPHOSPHORAMIDE.
    WESSON TW; PETTIS JL
    J Miss State Med Assoc; 1965 Feb; 6(2):46-9. PubMed ID: 14256280
    [No Abstract]   [Full Text] [Related]  

  • 4. PREVENTION ON RECURRENCE OF PTERYGIUM.
    MEACHAM CT
    Eye Ear Nose Throat Mon; 1965 May; 44():62-6 PASSIM. PubMed ID: 14291507
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of Thio-Tepa (thiethylene thiophosphoramide) in the postoperative period of pterygium. Personal experience in 71 eyes operated on during a period of more than 2 years of observation].
    Chervin M; Vaccaro GL; De Vecchi HP
    Arch Oftalmol B Aires; 1969 Oct; 44(10):306-9. PubMed ID: 4987519
    [No Abstract]   [Full Text] [Related]  

  • 6. ADJUVANT CHEMOTHERAPY (TRIETHYLENE THIOPHOSPHORAMIDE) WITH RADICAL MASTECTOMY AND RADIOTHERAPY IN BREAST CANCER.
    HANKINS GW; MCCARTEN AB
    Can Med Assoc J; 1963 Dec; 89(26):1305-9. PubMed ID: 14101448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pterygium treatment with triethylene thiophosphoramide.
    Chapman-Smith JS
    Aust N Z J Ophthalmol; 1992 May; 20(2):129-31. PubMed ID: 1389130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of corneal vascularization by triethylene thiophosphoramide (Thio-Tepa).
    ROCK RL
    Arch Ophthalmol; 1963 Mar; 69():330-4. PubMed ID: 13974584
    [No Abstract]   [Full Text] [Related]  

  • 9. Pterygium: prevention of recurrence by excision and postoperative thio-tepa.
    Cooper JC
    Eye Ear Nose Throat Mon; 1966 Oct; 45(10):59-62. PubMed ID: 4958505
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study on the use of triethylene thiophosphoramide (THIO-TEPA) in anticancer chemotherapy].
    BRULE G; BOIRON M; TRUHAUT R
    Pathol Biol; 1963; 11():742-54. PubMed ID: 14016230
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention of recurrence in the pterygium operation by means of an antimitotic cytolytic collyrium with triethylenethiophosphoramide base (Thio-Tepa) used from the immediate postoperative period].
    Allende FP
    Arch Oftalmol B Aires; 1969 Mar; 44(3):43-7. PubMed ID: 4979197
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of triethylene thiophosphoramide (thio-TEPA) in the treatment of incurable neoplastic disease.
    LEVINE B
    J Chronic Dis; 1960 Aug; 12():258-64. PubMed ID: 14416250
    [No Abstract]   [Full Text] [Related]  

  • 13. Incidence of pterygium recurrence in patients treated with thio-tepa.
    Joselson GA; Muller P
    Am J Ophthalmol; 1966 May; 61(5 Pt 1):891-2. PubMed ID: 16874991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of triethylene thiophosphoramide (thio-TEPA) in treatment of advanced cancer.
    ANDERSON MC; STALEY CJ; SCANLON EF; PRESTON FW
    AMA Arch Surg; 1957 Oct; 75(4):615-22; discussion 622-4. PubMed ID: 13457640
    [No Abstract]   [Full Text] [Related]  

  • 15. The treatment of advanced malignant melanoma with triethylene thiophosphoramide (Thio-TEPA or TSPA).
    GUMPORT SL; WRIGHT JC; GOLOMB FM
    Ann Surg; 1958 Feb; 147(2):232-8. PubMed ID: 13498644
    [No Abstract]   [Full Text] [Related]  

  • 16. The inhibition of pterygium recurrence by thio-tepa.
    Cassady JR
    Am J Ophthalmol; 1966 May; 61(5 Pt 1):886-8. PubMed ID: 16874989
    [No Abstract]   [Full Text] [Related]  

  • 17. [Thio-tepa eyedrops against recurrent pterygium and neovascularization of the cornea].
    Gourcuff A; Tassy A; Garron J; Perruchot PJ; Blondel P
    Bull Soc Ophtalmol Fr; 1984 May; 84(5):583-7. PubMed ID: 6085490
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of leukemia with triethylene thiophosphoramide (thio-TEPA); preliminary results in experimental and clinical leukemia.
    SHAY H; ZARAFONETIS C; SMITH N; WOLDOW I; SUN DC
    AMA Arch Intern Med; 1953 Nov; 92(5):628-45. PubMed ID: 13091480
    [No Abstract]   [Full Text] [Related]  

  • 19. Surgery, thio-tepa, and corticosteroid in the treatment of pterygium.
    Asregadoo ER
    Am J Ophthalmol; 1972 Nov; 74(5):960-3. PubMed ID: 4630176
    [No Abstract]   [Full Text] [Related]  

  • 20. Synergistic toxicity of triethylene thiophosphoramide and folic acid in the IRC-741 leukemia.
    MCKENZIE D; BRODY JI
    Cancer Res; 1963 Jan; 23():118-21. PubMed ID: 13932078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.